VeraSci's Innovation Lab would be incorporating ActiGraph's CentrePoint Insight Watch into an NIH-funded study examining the relationship between real-time measurements of actigraphy and gait collected by industry-grade wearables and established cognitive and functional endpoints that are sensitive to decline early in the Alzheimer's disease continuum.
Fremont, CA: VeraSci—a global clinical research company offering eClinical software, translation services, and expertise in endpoints and assessments—is pleased to declare a new partnership with ActiGraph, a leading provider of medical-grade wearable activity as well as sleep monitoring devices.
VeraSci's Innovation Lab would be incorporating ActiGraph's CentrePoint Insight Watch into an NIH-funded study examining the relationship between real-time measurements of actigraphy and gait collected by industry-grade wearables and established cognitive and functional endpoints that are sensitive to decline early in the Alzheimer's disease continuum.
Preliminary data have indicated a correlation between remotely captured actigraphy and gait measures and established cognition and function measures. These data suggest that wearables can offer meaningful information regarding cognitive health and may eventually contribute to continuous assessment of cognition and function in clinical trials.
"Wearables present an incredible opportunity to gather data in ways that haven't been feasible before. We can gather information directly while patients are engaged in their daily lives," stated VeraSci CEO Dr. Rich Keefe, "Our partnership with ActiGraph advances our commitment to pairing scientific knowledge with cutting-edge technology to improve the tools and measurements available in clinical trials."
"This partnership between ActiGraph and VeraSci provides an exciting opportunity to better understand the relationship between real-world physical behavior, function, and cognition," stated Matt Biggs, ActiGraph's Head of Business Operations. "We believe that these types of collaborations will help to jumpstart the creation of novel digital endpoints for global health communities."
The research reported in this launch was supported by the National Institute on Aging of the National Institutes of Health Small Business Innovation Research (SBIR) program under Award Number R44AG058345. The content is completely the responsibility of the authors and also does not necessarily represent the official views of the National Institutes of Health.
